DEF 14A: T Stamp Inc. Seeks Stockholder Approval for Key Financial Transactions and Reverse Stock Split

T Stamp Inc. is holding a special meeting of stockholders on November 18, 2024, to vote on proposals related to recent securities purchase agreements, warrant issuances, and a potential reverse stock split.

Summary

• T Stamp Inc. is convening a special meeting of stockholders on November 18, 2024, to vote on several key proposals.
• The proposals include ratifying the Securities Purchase Agreement with DQI Holdings, Inc. (DQI SPA), which involved the sale of 4,597,701 shares of Class A Common Stock to DQI at $0.435 per share.
• Stockholders will also vote on ratifying the issuance of Private Placement Warrants to Armistice Capital Master Fund Ltd., exercisable for up to 2,865,798 shares of Class A Common Stock at $0.3223 per share.
• Another proposal involves approving the issuance of up to 9,546,060 shares of Common Stock upon the exercise of new warrants issued to Armistice Capital Master Fund Ltd.
• Additionally, stockholders will vote on approving a reverse stock split of the Common Stock at a ratio of not less than 1-for-5 and not more than 1-for-50, to be determined by the Board of Directors by December 31, 2024.
• The company is seeking these approvals to comply with Nasdaq Listing Rules and to facilitate its financing activities.

Sentiment

Score: 4

Explanation: The document indicates financial challenges and reliance on potentially dilutive financing. While the company is taking steps to address these issues, the overall sentiment is cautiously negative due to the risks and uncertainties involved.

Positives

• The funding from the DQI SPA and Armistice transactions is expected to improve the company's capital position and provide financing for commercial growth, working capital, and general corporate purposes.
• The termination of transaction documents with HCM Management Foundation, funded by the Armistice SPA, is expected to benefit the company by removing anti-dilution provisions that hindered capital raising efforts.
• The potential reverse stock split aims to increase the stock price, potentially attracting institutional investors and improving marketability.
• The company has already received $2 million from DQI for the shares issued under the DQI SPA.

Negatives

• If the stockholders do not approve the DQI SPA, the company may be required to rescind the sale of shares to DQI, potentially leading to delisting from Nasdaq.
• If the stockholders do not approve the issuance of the Private Placement Warrants, the company will not receive up to $3.076 million from the exercise of these warrants, which could adversely impact the ability to fund operations.
• Approval of the proposals will lead to dilution of existing stockholders' ownership interests upon the issuance of new shares.
• The reverse stock split may not achieve the desired increase in stock price and could potentially reduce the company's market capitalization.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could lead to delisting, reducing liquidity and impairing the ability to raise capital.
• The reverse stock split may not increase the stock price proportionately or maintain the listing on Nasdaq.
• The company is dependent on stockholder approval for key financing transactions, and failure to obtain approval could have adverse financial consequences.
• The market price of the Class A Common Stock could be materially and adversely affected by the sale into the public market of shares issued upon exercise of warrants.

Future Outlook

The company intends to use the proceeds from the financing transactions for commercial growth, working capital, general corporate purposes, and to fund the termination of transaction documents with HCM Management Foundation. The company is seeking stockholder approval to proceed with these transactions and a potential reverse stock split to improve its financial position and comply with Nasdaq listing requirements.

Management Comments

• Gareth Genner, Chief Executive Officer, cordially invites stockholders to attend the Special Meeting.
• The Board of Directors believes that approval of the reverse stock split will provide maximum flexibility to react to current market conditions and act in the best interests of the stockholders.

Industry Context

The company's actions reflect a common strategy for companies facing Nasdaq listing compliance issues, where reverse stock splits are often used to increase share price. The private placement financings are indicative of the company's need for capital and its willingness to accept potentially dilutive terms to secure funding.

Comparison to Industry Standards

• Reverse stock splits are a common tool used by companies to regain compliance with minimum listing requirements, as seen with companies like Ocugen Inc. and Farmmi, Inc.
• Private placements are frequently used by small-cap companies to raise capital, but they often come with the risk of dilution, similar to what has been seen with companies like Biofrontera Inc.
• The terms of the warrants and the beneficial ownership limitations are typical in these types of financings to prevent a change of control without stockholder approval, similar to what has been seen with companies like Castor Maritime Inc.

Stakeholder Impact

• Shareholders will experience potential dilution of their ownership interests if the proposals are approved.
• The reverse stock split could affect the liquidity and transaction costs for shareholders.
• Employees may be impacted by the company's financial performance and ability to secure funding.
• The company's ability to meet its obligations to suppliers and creditors depends on its financial stability.

Next Steps

• Stockholders to vote on the proposals at the Special Meeting on November 18, 2024.
• Board of Directors to determine the ratio for the reverse stock split by December 31, 2024, if approved.
• Company to file a Current Report on Form 8-K with the SEC within four business days following the Special Meeting to announce the final voting results.

Key Dates

Keywords

reverse stock split, warrants, stockholder approval, DQI Holdings, Armistice Capital, Nasdaq Listing Rules, securities purchase agreement, common stock, financing, proxy statement